Achilles Therapeutics (ACHL)
undefined
undefined%
At close: undefined
0.99
0.01%
After-hours Dec 13, 2024, 04:31 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - -
Cost of Revenue 4.73M 3.69M 3.29M 778.00K 303.25K -
Gross Profit -4.73M -3.69M -3.29M -778.00K -303.25K -
Operating Income -75.25M -78.38M -64.19M -33.73M -13.78M -6.90M
Interest Income - - - - - -
Pretax Income -69.17M -71.06M -61.06M -33.20M -13.99M -6.89M
Net Income -69.67M -71.18M -61.10M -33.20M -13.99M -6.89M
Selling & General & Admin 12.34M 21.12M 21.97M 11.10M 4.70M 2.10M
Research & Development 67.65M 57.26M 42.22M 22.63M 9.07M 4.80M
Other Expenses -9.40M 7.32M 3.13M 531.00K -215.00K -
Operating Expenses 75.25M 78.38M 64.19M 33.73M 13.78M 6.89M
Interest Expense - - - - - -
Selling & Marketing Expenses -4.67M - - - - -
Cost & Expenses 75.25M 78.38M 64.19M 33.73M 13.78M 6.89M
Income Tax 491.00K 111.00K 37.00K 3.00K 130.14K -
Shares Outstanding (Basic) 39.97M 39.14M 28.65M 40.62M 1.64M 542.00K
Shares Outstanding (Diluted) 39.97M 39.14M 28.65M 40.62M 1.64M 542.59K
EPS (Basic) -1.74 -1.82 -2.13 -0.82 -8.52 -12.71
EPS (Diluted) -1.74 -1.82 -2.13 -0.82 -8.52 -12.69
EBITDA -70.44M -78.38M -57.77M -32.95M -13.47M -6.73M
Depreciation & Amortization 4.73M 3.69M 3.29M 778.00K 303.25K 173.00K